ArticlePloS one2026
The limited role of RGS10 on NFκB and cytokine transcript levels in peritoneal macrophages under the influence of opioid analgesics.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Regulator of G-protein signaling 10 (RGS10) has been shown to regulate multiple inflammatory pathways relevant to disease pathogenesis. Of particular importance is the ability of RGS10 to negatively regulate the NFkB pathway, a prominent pro-inflammatory pathway implicated in multiple inflammatory disease phenotypes. However, the exact mechanism by which RGS10 regulates NFκB is unknown. Given that RGS10 translocates to the nucleus upon stimulation, we hypothesize that RGS10 may regulate NFκB at the transcript level. To determine whether RGS10 influences NFκB transcript levels, we stimulated peritoneal macrophages from RGS10 Knockout (KO) and B6 mice and collected cell lysate and conditioned media over a 24-hour period to assess transcript levels of NFκB and related pro-inflammatory cytokines as well as secreted cytokine levels. Here we found a limited and transient influence of RGS10 on transcript levels of NFκB subunits and NFκB-dependent cytokines. However, RGS10 displayed a more robust negative regulation of secreted protein levels of certain pro-inflammatory cytokines. Importantly, this study required the use of opioid analgesics prior to the collection of peritoneal macrophages and therefore reflects the role of RGS10 on pro-inflammatory transcript and protein levels when opioid analgesics are present. Overall, this study indicates that RGS10 may not serve as an important transcriptional regulator of NFκB related cytokine production under the influence of opioid analgesics. Further studies are warranted to understand the influence of opioid analgesics on RGS10 function and the mechanism by which RGS10 regulates NFκB activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.